Nearly 40% have Long Covid after 7 months, finds Swiss study

Last update July 7, 2021

Investec July 7, 2021 SNB & CHF

by
Investec
My articles My books My videos
Follow on:Twitter

Summary:
The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months. © Wavebreakmedia Ltd | Dreamstime.com Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%). Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that

Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3a) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter

This could be interesting, too:

Investec writes Swiss health care costs continued to rise in 2022

Investec writes Swiss parliament rejects adding dental care to basic insurance

Vibhu Vikramaditya writes Navigating the Slippery Slope: How Hoover’s Interventions Paved the Way for the Great Depression

Ryan McMaken writes Frédéric Bastiat Was a Radical Opponent of War and Militarism

The longer term effects of Covid-19 can take many forms and there are numerous definitions of the disease. A study undertaken by HUG and UNIGE in Geneva, published on 6 July 2021, found that 39% of a group of Covid-19 patients still had symptoms after 7 months.

Nearly 40% have Long Covid after 7 months, finds Swiss study

Of the 629 participants in the study who completed the interviews, 410 completed the follow-up at 7 to 9 months after a COVID-19 diagnosis in early 2020. Of this group, 39.0% reported residual symptoms at 7 to 9 months. Fatigue (20.7%) was the most common symptom, followed by loss of taste or smell (16.8%), shortness of breath (11.7%), and headache (10.0%).

Some had symptoms that persisted, some had symptoms that arrived after a delay, while others had symptoms that came, went, and returned later.

Of the 311 participants that responded at all 3 follow-up time points, 37% reported symptom resolution by 30 to 45 days and 19% by 7 to 9 months. 27% reported symptoms at all 3 time points and 10% reported symptoms at the start and at 7 to 9 months but not at 30 to 45 days. Finally, 4% of participants reported no symptoms at all 3 time points, 2% had no symptoms at baseline but had symptoms at 30 to 45 days and 7 to 9 months, and 1 person had no symptoms at the start and 30 to 45 days but had symptoms at 7 to 9 months.

The study authors concluded that residual symptoms following SARS-CoV-2 infection are common among otherwise young and healthy persons and recommend long-term monitoring.

The mean age of those studied was 42.1 years, 60.9% were women, 25.3% were health care workers, and 70.7% had no underlying risk factors.